SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR
Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain. L'invention porte sur des composés...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZINDELL, RENEE, M HICKEY, EUGENE, RICHARD WHITTAKER, MARK RIETHER, DORIS AMOUZEGH, PATRICIA ERMANN, MONIKA THOMSON, DAVID, SMITH PALMER, CHRISTOPHER, FRANCIS |
| description | Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
L'invention porte sur des composés qui modulent le récepteur CB2. Les composés selon l'invention se lient à et sont agonistes du récepteur CB2 et sont utiles pour le traitement de l'inflammation. Les composés qui sont des agonistes sont en outre utiles pour le traitement de la douleur. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2009140089A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2009140089A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2009140089A33</originalsourceid><addsrcrecordid>eNrjZDAMDvVx8_dzVXD29w3wD_VzCVYI9_B09lDw9XcJ9XEMcVUI8QBKOhkpBLk6uwaE-AfxMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAwNLQxMDAwtLR2Nj4lQBAOp0J2w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR</title><source>esp@cenet</source><creator>ZINDELL, RENEE, M ; HICKEY, EUGENE, RICHARD ; WHITTAKER, MARK ; RIETHER, DORIS ; AMOUZEGH, PATRICIA ; ERMANN, MONIKA ; THOMSON, DAVID, SMITH ; PALMER, CHRISTOPHER, FRANCIS</creator><creatorcontrib>ZINDELL, RENEE, M ; HICKEY, EUGENE, RICHARD ; WHITTAKER, MARK ; RIETHER, DORIS ; AMOUZEGH, PATRICIA ; ERMANN, MONIKA ; THOMSON, DAVID, SMITH ; PALMER, CHRISTOPHER, FRANCIS</creatorcontrib><description>Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
L'invention porte sur des composés qui modulent le récepteur CB2. Les composés selon l'invention se lient à et sont agonistes du récepteur CB2 et sont utiles pour le traitement de l'inflammation. Les composés qui sont des agonistes sont en outre utiles pour le traitement de la douleur.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100128&DB=EPODOC&CC=WO&NR=2009140089A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100128&DB=EPODOC&CC=WO&NR=2009140089A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZINDELL, RENEE, M</creatorcontrib><creatorcontrib>HICKEY, EUGENE, RICHARD</creatorcontrib><creatorcontrib>WHITTAKER, MARK</creatorcontrib><creatorcontrib>RIETHER, DORIS</creatorcontrib><creatorcontrib>AMOUZEGH, PATRICIA</creatorcontrib><creatorcontrib>ERMANN, MONIKA</creatorcontrib><creatorcontrib>THOMSON, DAVID, SMITH</creatorcontrib><creatorcontrib>PALMER, CHRISTOPHER, FRANCIS</creatorcontrib><title>SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR</title><description>Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
L'invention porte sur des composés qui modulent le récepteur CB2. Les composés selon l'invention se lient à et sont agonistes du récepteur CB2 et sont utiles pour le traitement de l'inflammation. Les composés qui sont des agonistes sont en outre utiles pour le traitement de la douleur.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAMDvVx8_dzVXD29w3wD_VzCVYI9_B09lDw9XcJ9XEMcVUI8QBKOhkpBLk6uwaE-AfxMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAwNLQxMDAwtLR2Nj4lQBAOp0J2w</recordid><startdate>20100128</startdate><enddate>20100128</enddate><creator>ZINDELL, RENEE, M</creator><creator>HICKEY, EUGENE, RICHARD</creator><creator>WHITTAKER, MARK</creator><creator>RIETHER, DORIS</creator><creator>AMOUZEGH, PATRICIA</creator><creator>ERMANN, MONIKA</creator><creator>THOMSON, DAVID, SMITH</creator><creator>PALMER, CHRISTOPHER, FRANCIS</creator><scope>EVB</scope></search><sort><creationdate>20100128</creationdate><title>SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR</title><author>ZINDELL, RENEE, M ; HICKEY, EUGENE, RICHARD ; WHITTAKER, MARK ; RIETHER, DORIS ; AMOUZEGH, PATRICIA ; ERMANN, MONIKA ; THOMSON, DAVID, SMITH ; PALMER, CHRISTOPHER, FRANCIS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2009140089A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZINDELL, RENEE, M</creatorcontrib><creatorcontrib>HICKEY, EUGENE, RICHARD</creatorcontrib><creatorcontrib>WHITTAKER, MARK</creatorcontrib><creatorcontrib>RIETHER, DORIS</creatorcontrib><creatorcontrib>AMOUZEGH, PATRICIA</creatorcontrib><creatorcontrib>ERMANN, MONIKA</creatorcontrib><creatorcontrib>THOMSON, DAVID, SMITH</creatorcontrib><creatorcontrib>PALMER, CHRISTOPHER, FRANCIS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZINDELL, RENEE, M</au><au>HICKEY, EUGENE, RICHARD</au><au>WHITTAKER, MARK</au><au>RIETHER, DORIS</au><au>AMOUZEGH, PATRICIA</au><au>ERMANN, MONIKA</au><au>THOMSON, DAVID, SMITH</au><au>PALMER, CHRISTOPHER, FRANCIS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR</title><date>2010-01-28</date><risdate>2010</risdate><abstract>Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
L'invention porte sur des composés qui modulent le récepteur CB2. Les composés selon l'invention se lient à et sont agonistes du récepteur CB2 et sont utiles pour le traitement de l'inflammation. Les composés qui sont des agonistes sont en outre utiles pour le traitement de la douleur.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2009140089A3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T17%3A51%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZINDELL,%20RENEE,%20M&rft.date=2010-01-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2009140089A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |